investorscraft@gmail.com

Intrinsic ValueCheng De Lolo Company Limited (000848.SZ)

Previous Close$8.57
Intrinsic Value
Upside potential
Previous Close
$8.57

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2024 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

Cheng De Lolo Company Limited operates within China's competitive non-alcoholic beverage sector, specializing in the production and distribution of plant-based health drinks and foods. The company's core revenue model is built on manufacturing and selling branded beverages, primarily almond milk, sugar-free almond dew, and walnut dew, under its established Lulu brand. This positions it within the growing health-conscious consumer segment in China, catering to demand for alternatives to traditional dairy and sugary drinks. The company leverages its long-standing heritage, having been founded in 1950, to build brand trust and a loyal customer base. Its market position is that of a specialized, niche player focused on plant-based nutrition, competing against both large diversified beverage conglomerates and smaller regional producers. The 2022 name change to Cheng De Lolo Company Limited reflects a strategic emphasis on brand consolidation and national recognition beyond its Hebei province origins.

Revenue Profitability And Efficiency

For the fiscal period, the company reported robust revenue of CNY 3.29 billion, demonstrating significant market penetration for its specialized product line. Profitability is strong, with net income reaching CNY 666 million, translating to a high net profit margin of approximately 20.3%. The company generated substantial operating cash flow of CNY 630 million, which comfortably covered capital expenditures of CNY 215 million, indicating efficient conversion of earnings into cash and prudent reinvestment into the business.

Earnings Power And Capital Efficiency

Cheng De Lolo exhibits considerable earnings power, as evidenced by its diluted earnings per share of CNY 0.64. The company's capital efficiency is highlighted by its significant cash generation from operations relative to its asset base. The disparity between its modest capital expenditure requirements and its strong cash flow underscores a capital-light operational model that does not require heavy ongoing investment to maintain profitability and market position.

Balance Sheet And Financial Health

The company maintains an exceptionally strong balance sheet, characterized by a substantial cash and equivalents position of CNY 3.39 billion. This is complemented by minimal total debt of approximately CNY 140 million, resulting in a net cash position that signifies superior financial health and low financial risk. This robust liquidity provides a significant buffer against market volatility and ample resources for strategic initiatives or potential acquisitions.

Growth Trends And Dividend Policy

While specific growth rates are not provided, the company's solid profitability and strong cash position suggest a stable financial trajectory. It demonstrates a shareholder-friendly approach through its dividend policy, having paid a dividend per share of CNY 0.30. This payout represents a dividend yield that rewards investors while retaining ample earnings for future growth, reflecting a balanced capital allocation strategy.

Valuation And Market Expectations

With a market capitalization of approximately CNY 8.91 billion, the market assigns a valuation that reflects the company's niche leadership and high profitability. The stock's beta of 0.634 indicates lower volatility compared to the broader market, which is typical for defensive consumer staples companies. This valuation suggests investor confidence in the stability of its earnings and its position in the consumer defensive sector.

Strategic Advantages And Outlook

The company's primary strategic advantages include its long-established brand heritage, a focused product portfolio aligned with health trends, and an exceptionally strong financial position. The outlook is supported by growing consumer preference for plant-based beverages in China. Its net cash balance provides strategic flexibility to pursue organic growth or market consolidation opportunities, positioning it well to capitalize on sector tailwinds while navigating competitive pressures.

Sources

Company Filings (SZSE)Market Data

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2025202620272028202920302031203220332034203520362037203820392040204120422043204420452046204720482049

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount